Rapamycin blocks hepatoblastoma growth in vitro and in vivo implicating new treatment options in high-risk patients.
about
Hepatoblastoma: A Need for Cell Lines and Tissue Banks to Develop Targeted Drug TherapiesTowards an international pediatric liver tumor consensus classification: proceedings of the Los Angeles COG liver tumors symposiumEngineered measles virus Edmonston strain used as a novel oncolytic viral system against human hepatoblastoma.FAK Inhibition Decreases Hepatoblastoma Survival Both In Vitro and In Vivo.Drug choices in autoimmune hepatitis: part B--Nonsteroids.The mTOR pathway in hepatic malignancies.Current and prospective pharmacotherapy for autoimmune hepatitis.The dual targeting of insulin and insulin-like growth factor 1 receptor enhances the mTOR inhibitor-mediated antitumor efficacy in hepatocellular carcinoma.Phase I study of vinblastine and sirolimus in pediatric patients with recurrent or refractory solid tumors.Connectivity map identifies HDAC inhibition as a treatment option of high-risk hepatoblastomaCentral role of mTORC1 downstream of YAP/TAZ in hepatoblastoma development.Avatars to personalized medicine: of mice and men.
P2860
Q26751517-5C7D92C0-7AEC-4CDD-8754-18B76961BE6EQ26828479-659F9A89-C492-4888-921F-8FD0F0F8243EQ34421151-96284A88-7F92-454A-A409-2D94F5B53A0CQ36723758-51E73ECF-A17D-4034-8B59-BC93031FEC79Q38051706-7B975FA8-01F5-4BC5-B928-28272EA20072Q38081396-6A3CB9C8-426E-4D24-8770-F89AFAF1F4F4Q38222882-B2873200-5910-4EA0-96D4-92544088C934Q38804626-35FF015C-EA36-4CC5-8A53-43AD08F54437Q39365297-902FF321-DA0F-4A42-8178-DC5E15F9BBB9Q41728555-456E61A9-0296-4914-BFE6-ED1C7F5A0B91Q43088347-48229700-CDB5-46F6-A08C-D537DDE7B59CQ45909844-99768D72-445D-4ADB-8E5F-B737410DC5BC
P2860
Rapamycin blocks hepatoblastoma growth in vitro and in vivo implicating new treatment options in high-risk patients.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Rapamycin blocks hepatoblastom ...... options in high-risk patients.
@en
Rapamycin blocks hepatoblastom ...... options in high-risk patients.
@nl
type
label
Rapamycin blocks hepatoblastom ...... options in high-risk patients.
@en
Rapamycin blocks hepatoblastom ...... options in high-risk patients.
@nl
prefLabel
Rapamycin blocks hepatoblastom ...... options in high-risk patients.
@en
Rapamycin blocks hepatoblastom ...... options in high-risk patients.
@nl
P2093
P1476
Rapamycin blocks hepatoblastom ...... options in high-risk patients.
@en
P2093
Bente Henningsen
Christine Lederer
Dietrich von Schweinitz
Ferdinand Wagner
Jan Gödeke
Josef Müller-Höcker
Melanie Eichenmüller
Roland Kappler
P304
P356
10.1016/J.EJCA.2011.12.032
P577
2012-01-28T00:00:00Z